Core Viewpoint - The company, WanFang Urban Investment Development Co., Ltd., is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may lead to significant risks including potential delisting of its stock [1][2]. Group 1: Investigation and Regulatory Actions - On July 25, 2025, the company received a notice from the CSRC regarding the initiation of an investigation due to suspected violations of information disclosure laws [1]. - As of the latest announcement, the investigation is ongoing, and the company has not received any conclusive opinions or decisions from the CSRC [2]. - If the CSRC's findings lead to administrative penalties that fall under the major illegal circumstances defined by the Shenzhen Stock Exchange, the company's stock may face mandatory delisting [2]. Group 2: Stock Trading and Financial Performance - The company's stock experienced an abnormal trading fluctuation, with a cumulative closing price deviation of 12.58% over three consecutive trading days from December 31, 2025, to January 6, 2026 [4]. - The company confirmed that there were no significant changes in its operational situation or external business environment that could have influenced the stock price [6]. - As of September 30, 2025, the company reported total assets of 265.74 million yuan, net assets of 139.49 million yuan, and a revenue of 175.54 million yuan, with a net loss attributable to shareholders of 8.59 million yuan, representing a 164.64% decrease compared to the same period last year [8]. Group 3: Audit and Financial Reporting - The company received a qualified audit opinion from Zhongxing Caiguanghua Accounting Firm for its 2024 financial statements, indicating uncertainty regarding the recoverability of investments in Jilin WanFang Bai'ao Biotechnology Co., Ltd. [9]. - The company is at risk of receiving a qualified audit opinion for its 2025 financial statements, which could trigger delisting if it falls under the relevant rules of the Shenzhen Stock Exchange [9]. - As of January 6, 2026, the company's rolling price-to-earnings ratio was -140.23, significantly higher than the industry average of 136.71 [8].

Summary of Key Points Core Viewpoint - Jiangxi Mubang High-Tech Co., Ltd. faces significant financial challenges, including a negative net profit for 2024 and revenue below 300 million yuan, leading to a risk of delisting from the stock market starting May 6, 2025 [1][3]. Trading Information - On January 6, 2026, *ST Mubang (603398) closed at 9.06 yuan, up 4.38%, with a turnover rate of 3.62%, trading volume of 156,800 shares, and a transaction value of 141 million yuan [1]. - The net inflow of main funds was 4.87 million yuan, accounting for 3.46% of the total transaction value, while retail investors saw a net outflow of 4.60 million yuan, representing 3.27% of the total transaction value [1]. Company Announcements - The company announced that due to a negative net profit for 2024 and revenue below 300 million yuan, its stock will be subject to delisting risk warnings starting May 6, 2025 [1][3]. - The company is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, with no conclusive opinions available yet [1][3]. - For the period of January to September 2025, the company reported a net loss of 355.72 million yuan, and if financial indicators do not improve, the stock may be delisted [1][3].

Core Viewpoint - The announcement highlights significant trading risks associated with Sichuan Tianwei Electronics Co., Ltd. due to its high price-to-earnings (P/E) ratio compared to the industry average, alongside potential delisting risks stemming from financial performance issues in the previous fiscal year [2][7]. Market Trading Risks - As of January 6, 2026, the company's stock closed at 31.49 CNY per share, with a recent increase in price leading to a P/E ratio of 541.99, which is substantially higher than the defense equipment industry average P/E of 106.09 [2][4]. - Investors are advised to make cautious and rational decisions due to the significant volatility in the stock price [4][5]. Financial Performance Risks - The company disclosed that for the fiscal year 2024, it reported a negative net profit attributable to shareholders after deducting non-recurring gains and losses, and its revenue from core business activities fell below 100 million CNY, triggering a delisting risk warning effective May 6, 2025 [2][7]. Product Pricing Risks - A portion of the company's main products has not completed military pricing reviews, which may lead to fluctuations in operating performance due to uncertainties in the final approved prices compared to provisional prices [3][8]. - The military pricing review process is lengthy, and any significant downward adjustments in approved prices relative to provisional prices could adversely affect the company's financial results [3][8]. Revenue Adjustment Risks - The company’s system products, primarily military fire extinguishing and explosion suppression systems, are recorded at provisional prices until military approval is obtained. Any discrepancies between provisional and final prices will necessitate revenue adjustments, which could impact financial performance [3][8].

Core Viewpoint - The company, Zhengping Co., announced significant stock price volatility and irrational speculation from September 1, 2025, to January 6, 2026, indicating high trading risks [1] Financial Performance - As of the end of Q3 2025, the company's net assets attributable to shareholders were only 280 million yuan, with a potential risk of negative net assets due to asset impairment, which could lead to delisting [1] - The company's revenue for 2024 was 1.362 billion yuan, with a net loss attributable to shareholders of 484 million yuan [1] - For the first three quarters of 2025, the company reported revenue of 652 million yuan and a net loss attributable to shareholders of 99 million yuan [1] Debt and Restructuring - The company is undergoing a pre-restructuring process with partial debt claims, which may not resolve the issues related to the non-standard audit opinion for 2024 [1]

Core Viewpoint - ST Tianlong faces significant risks of being delisted due to negative net assets and ongoing operational challenges, with its future development highly uncertain [2][3][6] Group 1: Financial Performance and Risks - The company has been under financial distress since 2018, with its core photovoltaic equipment manufacturing business effectively ceasing operations due to a lack of orders [3][4] - Despite attempts to pivot to the renewable energy sector, the company has not achieved profitability, with a net loss of 8.58 million yuan in 2023 and an expanded loss of 27.3 million yuan in 2024 [3][6] - The company’s net assets turned negative for the first time in 2024, triggering financial delisting warnings [3][6] Group 2: Governance and Management Issues - Key management changes occurred with the resignation of the board secretary and financial officer, raising concerns about governance and management independence [4][5] - The company’s major shareholder, Guangzhou Longshuo, reduced its stake below 5%, reflecting negative investor sentiment [5] Group 3: Legal and Operational Challenges - Legal issues have compounded the company’s difficulties, with multiple bank accounts frozen due to contract disputes, impacting cash flow management [4][5] - The company is facing potential liabilities exceeding 10 million yuan due to supplier payment disputes [4] Group 4: Strategic Moves and Future Outlook - In an attempt to stabilize its financial situation, the company announced a donation of 25 million yuan from a related party to improve its net asset position [5][6] - However, the effectiveness of this financial maneuver is uncertain, as the company has already incurred losses exceeding 14 million yuan in the first three quarters of 2025 [6][7] - The reliance on one-time financial transactions to meet listing requirements without a sustainable business model raises concerns about the company's long-term viability [7]

*ST高斯公告称，公司股票于2025年12月30日、12月31日、2026年1月5日连续3个交易日收盘价格涨幅 偏离值累计超12%，属异常波动。经核实，公司前期信息无需更正补充，未发现重大未公开信息，经营 正常，不存在应披露未披露重大事项，控股股东等在异常波动期间无买卖公司股票情形。公司因2024年 相关指标不达标被实施"退市风险警示"和"其他风险警示"，若2025年经审计指标触及规定，股票将终止 上市。 ...

Core Viewpoint - The company has experienced a significant stock price increase of 28.25% over four consecutive trading days, indicating potential irrational speculation in the market [1] Financial Performance - For the year 2024, the company reported revenue of 1.362 billion and a net loss attributable to shareholders of 484 million [1] - In the first three quarters of 2025, the company generated revenue of 652 million with a net loss attributable to shareholders of 99 million [1] - As of the end of the third quarter of 2025, the company's net assets attributable to shareholders stood at 280 million [1] Risks and Concerns - The company faces risks of being delisted due to the possibility of negative audited net assets for the year 2025, stemming from asset impairment or undisclosed debts [1] - The pre-restructuring debt claims have been partially submitted, which does not alleviate the issues related to the non-standard audit opinion for 2024 [1]

截至12月30日收盘，*ST长药的股价报0.95元/股，下跌19.49%，总市值约3亿元。 12月30日晚间，长江医药控股股份有限公司（以下简称*ST长药，300391.SZ）发布公告称，公司股票 收盘价首次低于1元，可能因连续二十个交易日股票收盘价低于1元而被终止上市。同时，公司因涉嫌定 期报告等财务数据虚假记载被证监会立案调查，可能触及重大违法强制退市情形。 此外，*ST长药2024年度期末净资产为负，若2025年度期末净资产继续为负，将被实施财务类强制退 市。公司还面临诉讼、仲裁案件风险，大额有息负债逾期风险，账户冻结风险以及大额欠税风险。 公告显示，12月26日，*ST长药收到中国证监会下发的《行政处罚事先告知书》，认定公司2021年、 2022年、2023年的年度报告存在虚假记载。 12月29日晚间，*ST长药发布公告称，收到十堰中院送达的《民事裁定书》和《决定书》，法院裁定不 予受理十堰市郧胥工贸有限公司对公司的重整申请，决定依法终结公司预重整程序。法院认为，依照相 关规定，长药控股在预重整期间未能提交预重整方案，明显缺乏重整可行性。同日，公司收到另一份法 院的《民事裁定书》，裁定终止*ST长药的 ...

Core Viewpoint - *ST Changyao is facing multiple delisting risks due to its stock price falling below par value, suspected financial data falsification, and an expected negative net asset at the end of the period, which has attracted significant market attention [1] Group 1: Stock Price and Listing Rules - On December 30, 2025, *ST Changyao's stock closed at 0.95 yuan per share, marking the first instance of the closing price falling below 1 yuan [3] - According to the Shenzhen Stock Exchange's listing rules, if the stock price remains below 1 yuan for twenty consecutive trading days, it will face delisting [3] - The company is required to issue a risk warning announcement the day after the first occurrence of the stock price falling below 1 yuan and must continue to disclose risks if the situation persists [3] Group 2: Regulatory Investigations and Financial Irregularities - On November 7, 2025, *ST Changyao received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation for suspected financial data falsification [3] - The CSRC issued a prior notice of administrative penalty on December 26, 2025, indicating that the company had inflated its revenue by 215 million yuan, 284 million yuan, and 234 million yuan for the years 2021, 2022, and 2023, respectively [4] - The inflated profits for the same years were reported as 56.4 million yuan, 63.4 million yuan, and 43.7 million yuan, representing 35.62%, 88.23%, and 6.42% of the disclosed profit totals [4] Group 3: Financial Condition and Risks - As of the end of 2024, the audited net assets attributable to shareholders were -433 million yuan, leading to a delisting risk warning [5] - By the end of the third quarter of 2025, the net assets further declined to -643 million yuan, with an expectation of negative net assets by December 31, 2025, which could trigger financial delisting conditions [5] - The company is involved in 152 litigation and arbitration cases, with a total amount of 1.932 billion yuan, which is 446% of the latest audited net assets [5] - The company has significant interest-bearing debts of 1.106 billion yuan, with overdue debts amounting to 390 million yuan, impacting its repayment capacity [5]

Core Viewpoint - *ST Changyao's stock price has fallen below 1 yuan for the first time, potentially leading to delisting due to continuous trading below this threshold and ongoing investigations by the China Securities Regulatory Commission (CSRC) for financial misconduct [2][4][6] Financial Performance - The company reported a negative net asset value of -433 million yuan for the end of 2024, which could trigger mandatory delisting if the negative trend continues into 2025 [5] - The audited net profits for 2022, 2023, and 2024 were -76.39 million yuan, -632 million yuan, and -569 million yuan respectively, indicating a consistent decline in financial performance [5] Legal and Regulatory Issues - The CSRC has identified that *ST Changyao inflated revenue and profits for three consecutive years, leading to proposed fines of 10 million yuan for the company and 31 million yuan for 14 responsible individuals [6] - The company is under investigation for potential major violations that could result in delisting, with the Shenzhen Stock Exchange initiating delisting procedures [6] Court Proceedings - The company faced a court ruling that rejected its restructuring application, indicating a lack of feasibility for reorganization [3] - The court also terminated the substantive merger restructuring process for *ST Changyao and six other companies, declaring them bankrupt [3]